METFORMIN USAGE TO INDUCE OVULATION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME: META-ANALYSIS

Laiza Maria Steimbach; Aline Dos Santos LouÃ‡Ãƒo; Claudia Batista Carraro; Fernanda Stumpf Tonin; Roberto Pontarolo; Andreia Cristina Conegero Sanches

doi:10.22159/ijpps.2016v8i11.9517

Authors

Laiza Maria Steimbach ParanÃ¡ Federal University, UFPR, Curitiba, ParanÃ¡, Brazil
Aline Dos Santos LouÃ‡Ãƒo University Estadual do Oeste do ParanÃ¡, UNIOESTE, Cascavel, ParanÃ¡, Brazil
Claudia Batista Carraro University Estadual do Oeste do ParanÃ¡, UNIOESTE, Cascavel, ParanÃ¡, Brazil
Fernanda Stumpf Tonin ParanÃ¡ Federal University, UFPR, Curitiba, ParanÃ¡, Brazil
Roberto Pontarolo ParanÃ¡ Federal University, UFPR, Curitiba, ParanÃ¡, Brazil
Andreia Cristina Conegero Sanches University Estadual do Oeste do ParanÃ¡, UNIOESTE, Cascavel, ParanÃ¡, Brazil

DOI:

https://doi.org/10.22159/ijpps.2016v8i11.9517

Keywords:

Ovulation induction, Pregnancy, Polycystic Ovary Syndrome, Metformin, Meta-analysis

Abstract

Objective: To evaluate the use of MET in ovulation induction and pregnancy rates in a woman with polycystic ovary syndrome (PCOS).

Methods: A meta-analysis of randomised clinical trials (RCT) that presented ovulation and gestation rates in women with PCOS, after administering CC or M et al. one or combined was performed. The studies were selected according to the inclusion criteria in PCOS patients, resistant to CC or not.

Results: The meta-analysis demonstrated that MET and CC did not significantly increase the ovulation (Odds Ratio 1.72 [0.71, 4.12]) and gestation (OR 1.33 [0.88, 2.02]) rates when compared to the usage of CC itself in women not resistant to CC. However, in women with CC-resistant PCOS, the group treated with CC and MET presented higher rates of ovulation (Odds Ratio = 14.57 [4.96, 42.81]) and gestation (Odds Ratio = 11.86 [2.45, 57.36]) than patients treated only with CC.

Conclusion: The combination of MET and CC did not show advantages over the administration of CC alone in women not resistant to CC. However, MET may show satisfactory results in women resistant to CC.

Downloads

Download data is not yet available.

References

GÅ‘dÃ©ny S, Csenteri O. Importance of the interdisciplinary, evidence-based diagnosis of polycystic ovary syndrome. Orv Hetil 2014;155:1175-88.

DÃaz JFJ, GonzÃ¡lez CO. SÃndrome de ovario poliquÃstico. Rev Mexicana Med ReproducciÃ³n 2011;4:51-62.

AL-Inany H, JOHNSON N. Drugs for anovulatory infertility in polycystic ovary syndrome: reserve metformin for second line treatment for women with clomifene resistance. Br Med J 2006;332:1461â€“2.

SEMPR: ServiÃ§o de endocrinologia e metabologiaâ€“hospital das clÃnicas da universidade federal do paranÃ¡. DisponÃvel em: Available from http://www.sempr.org.br/protocolos/ proto-colo06.asp. [Last accessed on 17 Mar 2014].

Amin M, Abdel-Kareem O, Takekida S, Moriyama T, Abdel-Aal G, MARUO T. Update management of non-responder to clomiphene citrate in polycystic ovary syndrome. Kobe J Med Sci 2003;49:59â€“73.

Costello MF, Eden JA. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril 2003;79:1â€“13.

Kazerooni T, Ghaffarpasand F, Kazerooni Y, Setoodeh S. Short-term metformin treatment for clomiphene citrate-resistant women with polycystic ovary syndrome. Int J Gynaecol Obstet 2009;107:50-3.

American College of Obstetricians and gynaecologists (ACOG). management of infertility caused by ovulatory dysfunction. Washington, DC. Practice bulletin; 2002. p. 34.

Panidis D, Tziomalos K, Papadakis E, Katsikis I. Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery. Front Horm Res 2013;40:128-41.

Abu Hashim H, EL Lakany N, Sherief L. Combined metformin and clomiphene citrate versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomised controlled trial. J Obstet Gynaecol Res 2011;37:169-77.

Begum MR, Akhter S, Ehsan M, Begum MS, Khan F. Pretreatment and co-administration of the oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome. J Obstet Gynaecol Res 2013;39:966-73.

Moll E, bossuyt PMM, Korevaar JC, Lambalk CB, Van Der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double-blind clinical trial. Br Med J 2006;332:1485.

Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure while facilitating normal menses and pregnancy. Metabolism 1994;43:647-54.

Santana LF, Ferriani RA, SÃ¡ MFS, Reis RM. Tratamento da infer tilidate em mulheres com sÃndrome dos ovÃ¡rios policÃsticos. Rev Bras Ginecol Obstet 2008;30:201-9.

Johnson N. Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials. Aust N Z J Obstet Gynaecol 2011;51:125-9.

Misso ML, Costello MF, Garrubba M, Wong J, Rombauts L, Melder AM, et al. Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2013;19:2-11.

Xiao J, Chen S, Zhang C, Chang S. The effectiveness of metformin ovulation induction treatment in patients with PCOS: a systematic review and meta-analysis. Gynecol Endocrinol 2012;28:956-60.

Sun X, Zhang D, Zhang W. Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomised controlled trials. Arch Gynecol Obstet 2013;288:423-30.

Siebert TI, Viola MI, Steyn DW, Kruger TF. Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis. Gynecol Obstet Invest 2012;73:304-13.

Wang LL, Ren W, Cheng QF, Fan XD. Therapeutic effect of metformin for clomiphene-resistant infertility patients with polycystic ovary syndrome: a systematic analysis. Zhonghua Fuchanke Zazhi 2012;47:659-63.